HMGB2 and melanoma: We then tested the role of HMGB2 in drug tolerance in vivo by transplanting human melanoma cells overexpressing HMGB2 into athymic mice and treating the resulting tumours with dabrafenib and trametinib, widely used targeted therapies in melanoma61 (Fig. 5n).